MEDICAL SERVICES

Specialties

Departments

Programs

Languages

  • English

  • Spanish

EDUCATION

Undergraduate Degree

  • University of California San Diego , 1999 , San Diego , California

Medical School

  • University of Southern California School of Medicine , 2003 , Los Angeles , California

Internship

Pediatric Primary Care
  • Boston Combined Residency Program (BCRP) , 2004 , Boston , MA

Residency

Pediatric Primary Care Track
  • Boston Combined Residency Program (BCRP) , 2006 , Boston , MA

Fellowship

Pediatric Gastroenterology, Hepatology, and Nutrition
  • University of California , 2010 , San Diego , CA

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Gastroenterology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2020 Mar; 8(3):1107-1109. View abstract
  2. Respiratory symptoms associated with eosinophilic esophagitis. Pediatr Pulmonol. 2018 11; 53(11):1587-1591. View abstract
  3. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis. J Pediatr Gastroenterol Nutr. 2018 03; 66(3):395-397. View abstract
  4. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20. View abstract
  5. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View abstract
  6. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol. 2014 Nov; 49(11):1090-6. View abstract
  7. Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1011; author reply 1011-2. View abstract
  8. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011 Oct; 53(4):409-16. View abstract
  9. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis. 2008 Nov; 28(4):380-5. View abstract